<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/"><channel><title>PeptideScanner evidence for Thymopentin</title><link>https://peptidescanner.com/peptides/thymopentin/</link><description>Versioned, source-linked PeptideScanner evidence objects for Thymopentin. Selected coverage; not medical advice.</description><language>en-us</language><atom:link href="https://peptidescanner.com/feeds/peptides/thymopentin.xml" rel="self" type="application/rss+xml"/><item><title>ClinicalTrials.gov record NCT00002049</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct00002049-thymopentin/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct00002049-thymopentin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/thymopentin.json#clinicaltrials-gov-nct00002049-thymopentin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2005-06-24. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT00002050</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct00002050-thymopentin/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct00002050-thymopentin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/thymopentin.json#clinicaltrials-gov-nct00002050-thymopentin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2005-06-24. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT00002051</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct00002051-thymopentin/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct00002051-thymopentin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/thymopentin.json#clinicaltrials-gov-nct00002051-thymopentin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2005-06-24. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT00002066</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct00002066-thymopentin/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct00002066-thymopentin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/thymopentin.json#clinicaltrials-gov-nct00002066-thymopentin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2005-06-24. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT00002109</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct00002109-thymopentin/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct00002109-thymopentin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/thymopentin.json#clinicaltrials-gov-nct00002109-thymopentin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2005-06-24. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT00002289</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct00002289-thymopentin/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct00002289-thymopentin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/thymopentin.json#clinicaltrials-gov-nct00002289-thymopentin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2005-06-24. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT00002332</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct00002332-thymopentin/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct00002332-thymopentin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/thymopentin.json#clinicaltrials-gov-nct00002332-thymopentin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2005-06-24. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>Thymopentin treatment in severe atopic dermatitis--clinical and immunological evaluations.</title><link>https://peptidescanner.com/stories/pubmed-pmid-1329673-thymopentin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-1329673-thymopentin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/thymopentin.json#pubmed-pmid-1329673-thymopentin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2019-05-01. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>[Evaluation of the use of thymopentin in patients with progressive systemic sclerosis].</title><link>https://peptidescanner.com/stories/pubmed-pmid-1828204-thymopentin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-1828204-thymopentin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/thymopentin.json#pubmed-pmid-1828204-thymopentin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2013-11-21. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Investigations on cell-mediated immunity in patients with breast and ovarian carcinomas receiving a combination of chemotherapy and immunotherapy with thymopentin.</title><link>https://peptidescanner.com/stories/pubmed-pmid-2232966-thymopentin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-2232966-thymopentin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/thymopentin.json#pubmed-pmid-2232966-thymopentin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2013-11-21. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>[Peridural analgesia with dexamethasone and thymopentin: influence of the hypothalamo-hypophyseal axis].</title><link>https://peptidescanner.com/stories/pubmed-pmid-2290529-thymopentin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-2290529-thymopentin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/thymopentin.json#pubmed-pmid-2290529-thymopentin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2013-11-21. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Thymopentin (TP-5) in the treatment of rheumatoid arthritis.</title><link>https://peptidescanner.com/stories/pubmed-pmid-2650797-thymopentin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-2650797-thymopentin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/thymopentin.json#pubmed-pmid-2650797-thymopentin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2019-08-28. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Immunomodulation with thymopentin: in vitro studies.</title><link>https://peptidescanner.com/stories/pubmed-pmid-2657246-thymopentin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-2657246-thymopentin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/thymopentin.json#pubmed-pmid-2657246-thymopentin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2019-10-29. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Thymopentin in dermatology.</title><link>https://peptidescanner.com/stories/pubmed-pmid-2663371-thymopentin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-2663371-thymopentin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/thymopentin.json#pubmed-pmid-2663371-thymopentin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2019-10-29. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Thymopentin treatment of herpes simplex infections. An open, monitored, multicenter study.</title><link>https://peptidescanner.com/stories/pubmed-pmid-2863860-thymopentin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-2863860-thymopentin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/thymopentin.json#pubmed-pmid-2863860-thymopentin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2026-10-20. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Thymopoietin to thymopentin: experimental studies.</title><link>https://peptidescanner.com/stories/pubmed-pmid-2994196-thymopentin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-2994196-thymopentin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/thymopentin.json#pubmed-pmid-2994196-thymopentin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2019-11-01. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Tetrahydro-β-carboline-3-carboxyl-thymopentin: a nano-conjugate for releasing pharmacophores to treat tumor and complications.</title><link>https://peptidescanner.com/stories/pubmed-pmid-32263105-thymopentin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-32263105-thymopentin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/thymopentin.json#pubmed-pmid-32263105-thymopentin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2020-04-08. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Experience with thymopentin in the treatment of periarthritis humeroscapularis, tendinitis, and gonarthrosis by local infiltration.</title><link>https://peptidescanner.com/stories/pubmed-pmid-3284530-thymopentin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-3284530-thymopentin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/thymopentin.json#pubmed-pmid-3284530-thymopentin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2013-11-21. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Preformulation studies of thymopentin: analytical method development, physicochemical properties, kinetic degradation investigations and formulation perspective.</title><link>https://peptidescanner.com/stories/pubmed-pmid-35234086-thymopentin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-35234086-thymopentin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/thymopentin.json#pubmed-pmid-35234086-thymopentin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2022-06-22. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>A prospective study of thymopentin in severely burned patients.</title><link>https://peptidescanner.com/stories/pubmed-pmid-3554564-thymopentin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-3554564-thymopentin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/thymopentin.json#pubmed-pmid-3554564-thymopentin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2013-11-21. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Thymopentin treatment of selective IgA deficiency.</title><link>https://peptidescanner.com/stories/pubmed-pmid-3898285-thymopentin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-3898285-thymopentin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/thymopentin.json#pubmed-pmid-3898285-thymopentin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2019-11-01. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Thymopentin treatment in patients with chemotherapy-resistant lepromatous leprosy.</title><link>https://peptidescanner.com/stories/pubmed-pmid-3898294-thymopentin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-3898294-thymopentin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/thymopentin.json#pubmed-pmid-3898294-thymopentin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2026-10-11. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Thymopentin in active rheumatoid arthritis. An open, monitored study in 16 patients.</title><link>https://peptidescanner.com/stories/pubmed-pmid-3898297-thymopentin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-3898297-thymopentin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/thymopentin.json#pubmed-pmid-3898297-thymopentin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2026-10-20. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Structural analysis of Salvia miltiorrhiza polysaccharide and its regulatory functions on T cells subsets in tumor-bearing mice combined with thymopentin.</title><link>https://peptidescanner.com/stories/pubmed-pmid-39002910-thymopentin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-39002910-thymopentin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/thymopentin.json#pubmed-pmid-39002910-thymopentin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2024-08-24. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Self-assembled Palmitic Acid-modified Thymopentin Functions as a Delivery System of Nanovaccine for Cancer Immunotherapy.</title><link>https://peptidescanner.com/stories/pubmed-pmid-39814680-thymopentin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-39814680-thymopentin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/thymopentin.json#pubmed-pmid-39814680-thymopentin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2025-05-22. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Immunomodulation with thymopentin in humans.</title><link>https://peptidescanner.com/stories/pubmed-pmid-6398312-thymopentin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-6398312-thymopentin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/thymopentin.json#pubmed-pmid-6398312-thymopentin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2017-11-16. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Thymopentin treatment of rheumatoid arthritis.</title><link>https://peptidescanner.com/stories/pubmed-pmid-7818590-thymopentin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-7818590-thymopentin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/thymopentin.json#pubmed-pmid-7818590-thymopentin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2013-11-21. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Management of viral infections with thymopentin.</title><link>https://peptidescanner.com/stories/pubmed-pmid-7945525-thymopentin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-7945525-thymopentin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/thymopentin.json#pubmed-pmid-7945525-thymopentin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2013-11-21. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Thymopentin prophylactic treatment in patients with recurrent respiratory infections.</title><link>https://peptidescanner.com/stories/pubmed-pmid-8260339-thymopentin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-8260339-thymopentin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/thymopentin.json#pubmed-pmid-8260339-thymopentin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2013-11-21. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>The prognostic significance of serum viral load, codon 215 reverse transcriptase mutation and CD4+ T cells on progression of HIV disease in a double-blind study of thymopentin.</title><link>https://peptidescanner.com/stories/pubmed-pmid-8838703-thymopentin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-8838703-thymopentin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/thymopentin.json#pubmed-pmid-8838703-thymopentin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2019-07-18. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>[Recurrent urinary tract infections. Biological suppositions and clinical treatment with thymopentin].</title><link>https://peptidescanner.com/stories/pubmed-pmid-9557507-thymopentin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-9557507-thymopentin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/thymopentin.json#pubmed-pmid-9557507-thymopentin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2017-01-26. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Thymopentin and splenopentin as immunomodulators. Current status.</title><link>https://peptidescanner.com/stories/pubmed-pmid-9638477-thymopentin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-9638477-thymopentin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/thymopentin.json#pubmed-pmid-9638477-thymopentin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2026-10-11. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item></channel></rss>
